NIH Global Health Funding

In addition to Fogarty-supported programs and the trans-NIH programs and collaborations Fogarty is involved in, many Institutes and Centers at NIH offer funding opportunities to support research on global health topics, or in areas relevant to global health.

Current global health funding opportunities from across NIH

• Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) (PAR-18-335)
  Expiration Date: August 1, 2020
• Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) (PAR-18-801) and (R41/R42 - Clinical Trial Optional) (PAR-18-802)
  Expiration Date: January 6, 2021
• International Research Collaboration on Drug Abuse and Addiction Research (R01 - Clinical Trial Optional) (PA-18-773)
  Expiration Date: May 8, 2021
• NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) (PAR-19-258)
  Expiration Date: September 8, 2021
• Co-infection and Cancer (R01 Clinical Trial Not Allowed) (PAR-20-062) and (R21 Clinical Trial Not Allowed) (PAR-20-061)
  Expiration Date: January 8, 2023
• Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (NOT-CA-20-022)
  Applies to due dates on or after May 7, 2020, and subsequent receipt dates through January 8, 2023.

Other NIH global health funding resources

• Search all NIH Funding Opportunities and Notices
• Subscribe to the NIH Weekly Guide for Grants and Contracts
• More about Global Health at NIH

Updated January 27, 2019